Research programme: dipeptide repeat inhibitor vaccine - Vaxxinity
Alternative Names: DRP inhibitor vaccine - VaxxinityLatest Information Update: 30 Apr 2021
At a glance
- Originator Vaxxinity
- Class Antidementias; Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Amyotrophic lateral sclerosis; Dementia
Most Recent Events
- 14 Apr 2021 Preclinical trials in Amyotrophic lateral sclerosis in USA (Unspecified) prior to April 2021 (Vaxxinity pipeline, April 2021)
- 14 Apr 2021 Preclinical trials in Dementia in USA (Unspecified) prior to April 2021 (Vaxxinity pipeline, April 2021)